NCT03889795 2025-10-20
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
University of Toledo
Phase 1 Active not recruiting
Clinical Trials
14 trialsNCT04141995 2025-08-07
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
University of Nebraska
Phase 2 Terminated
NCT07025850 2025-08-01
Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer
Fudan University
Phase 1/2 Not yet recruiting
NCT01162135 2025-05-04
Digoxin for Recurrent Prostate Cancer
Thomas Jefferson University
Phase 2 Completed
NCT06030622 2024-04-19
C3
State University of New York - Downstate Medical Center
Phase 1/2 Recruiting
NCT05507775 2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA Completed
NCT03928210 2023-12-13
Digoxin Induced Dissolution of CTC Clusters
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Completed
NCT03113071 2021-03-16
Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
Fox Chase Cancer Center
Phase 1/2 Terminated
NCT01763931 2020-01-31
DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02138292 2018-05-15
A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma
University of Texas Southwestern Medical Center
Phase 1 Completed
NCT02915666 2018-05-15
A Clinical Trial of Patients With Melanoma
University of Texas Southwestern Medical Center
Phase 1 Withdrawn
NCT00281021 2018-03-29
Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
University of Louisville
Phase 2 Terminated
NCT01887288 2018-02-22
Capecitabine With Digoxin for Metastatic Breast Cancer
Western Regional Medical Center
Phase 2 Terminated
NCT02906800 2017-10-19
DIGHANC
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Unknown